Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-035994
Filing Date
2025-04-17
Accepted
2025-04-17 16:00:48
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 8870
2 EXHIBIT 1 tm2512569d1_ex1.htm EX-99.1 4688
  Complete submission text file 0001104659-25-035994.txt   15390
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Subject) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-87928 | Film No.: 25847162
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 399 PARK AVENUE NEW YORK NY 10022
Business Address 399 PARK AVENUE NEW YORK NY 10022 (212) 841-4100
MILLENNIUM MANAGEMENT LLC (Filed by) CIK: 0001273087 (see all company filings)

EIN.: 133804139 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A